Paraskevi Bilika

Dr. Paraskevi Bilika

Physiotherapy, University of Thessaly, Lamía, Stereá Elláda, Greece
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Jo NijsJo Nijs
Jo Nijs
ALAstrid Lahousse
Astrid Lahousse
Eleni KapreliEleni Kapreli
Eleni Kapreli
Paraskevi BilikaParaskevi Bilika
Paraskevi Bilika
ISIsmail Saracoglu
Ismail Saracoglu
EHEva Huysmans
Eva Huysmans
Recently, the International Association for the Study of Pain (IASP) released clinical criteria and a grading system for nociplastic pain affecting the musculoskeletal system. These criteria replaced the 2014 clinical criteria for predominant central sensitization (CS) pain and accounted for clinicians’ need to identify (early) and correctly classify patients having chronic pain according to the pain phenotype. Still, clinicians and researchers can become confused by the multitude of terms and the variety of clinical criteria available. Therefore, this paper aims at (1) providing an overview of what preceded the IASP criteria for nociplastic pain (‘the past’); (2) explaining the new IASP criteria for nociplastic pain in comparison with the 2014 clinical criteria for predominant CS pain (‘the present’); and (3) highlighting key areas for future implementation and research work in this area (‘the future’). It is explained that the 2021 IASP clinical criteria for nociplastic pain are in line with the 2014 clinical criteria for predominant CS pain but are more robust, comprehensive, better developed and hold more potential. Therefore, the 2021 IASP clinical criteria for nociplastic pain are important steps towards precision pain medicine, yet studies examining the clinimetric and psychometric properties of the criteria are urgently needed.

25 January 2023 in British Journal of Anaesthesia
Verified
Journal Article
Open access
Jo NijsJo Nijs
Jo Nijs
ALAstrid Lahousse
Astrid Lahousse
César Fernandez-de-las-PeñasCésar Fernandez-de-las-Peñas
César Fernandez-de-las-Peñas
PMPascal Madeleine
Pascal Madeleine
CFChristel Fontaine
Christel Fontaine
ISIsmail Saracoglu
Ismail Saracoglu
Nociplastic pain syndromes include particular fibromyalgia, irritable bowel syndrome, headache, complex regional pain syndrome, and idiopathic orofacial pain. Several mechanisms have been proposed to account for nociplastic pain including central sensitisation, alterations of pain modulatory controls, epigenetic changes, and peripheral mechanisms. Importantly, nociplastic pain might also be present in patients with cancer pain, particularly those with pain related to complications of cancer treatment. Increased awareness of nociplastic pain associated with cancer should have important implications for monitoring and managing such patients.

30 August 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
Paraskevi BilikaParaskevi Bilika
Paraskevi Bilika
Jo NijsJo Nijs
Jo Nijs
EFEmmanouil Fandridis
Emmanouil Fandridis
ZDZacharias Dimitriadis
Zacharias Dimitriadis
Nikolaos StrimpakosNikolaos Strimpakos
Nikolaos Strimpakos
Eleni KapreliEleni Kapreli
Eleni Kapreli
The recognition of central sensitization (CS) is crucial, as it determines the results of rehabilitation. The aim of this study was to examine associations between CS and catastrophizing, functionality, disability, illness perceptions, kinesiophobia, anxiety, and depression in people with chronic shoulder pain (SP). In this cross-sectional study, 64 patients with unilateral chronic SP completed a few questionnaires including the Central Sensitization Inventory, the Oxford Shoulder Score, the Tampa Scale for Kinesiophobia, the Hospital Anxiety and Depression Scale, the Pain Catastrophizing Scale, the Brief Illness Perception Questionnaire and the “arm endurance” test. On the basis of three constructed linear regression models, it was found that pain catastrophizing and depression (model 1: p < 0.001, R = 0.57, R2 = 0.33), functionality (model 2: p < 0.001, R = 0.50, R2 = 0.25), and helplessness (model 3: p < 0.001, R = 0.53, R2 = 0.28) were significant predictors for CS symptoms in chronic SP. Two additional logistic regression models also showed that depression (model 4: p < 0.001, Nagelkerke R2 = 0.43, overall correct prediction 87.5%) and functionality (model 5: p < 0.001, Nagelkerke R2 = 0.26, overall correct prediction 84.4%) can significantly predict the classification of chronic SP as centrally sensitized. Patients who were classified as centrally sensitized (n = 10) were found to have significantly worse functionality, psychological factors (anxiety, depression, kinesiophobia, catastrophizing), and pain intensity (p < 0.05). Catastrophizing, depression, and functionality are predictive factors of CS symptoms in patients with chronic shoulder pain. Health care providers should adopt a precision medicine approach during assessment and a holistic rehabilitation of patients with unilateral chronic SP.

12 October 2019 in Pain Practice
Verified
Journal Article
Closed access
PDF file
Paraskevi BilikaParaskevi Bilika
Paraskevi Bilika
RNRandy Neblett
Randy Neblett
GGGeorge Georgoudis
George Georgoudis
ZDZacharias Dimitriadis
Zacharias Dimitriadis
EFEmmanouil Fandridis
Emmanouil Fandridis
Eleni KapreliEleni Kapreli
Eleni Kapreli

28 August 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
Paraskevi BilikaParaskevi Bilika
Paraskevi Bilika
NKNatalia Karampatsou
Natalia Karampatsou
GSGIORGOS STAVRAKAKIS
GIORGOS STAVRAKAKIS
APACHILLEAS PALIOURAS
ACHILLEAS PALIOURAS
YTYannis Theodorakis
Yannis Theodorakis
Eleni KapreliEleni Kapreli
Eleni Kapreli
This scoping review aimed to identify interventions utilizing virtual-reality-based exercise therapy in patients with chronic musculoskeletal pain. Searches were conducted in four databases using descriptors related to virtual reality, exercise, and chronic musculoskeletal pain. Two reviewers screened the titles and abstracts of the studies to assess eligibility, with a third author resolving any discrepancies. Data were extracted and summarized in a narrative format by three independent raters. Clinical trials were evaluated using the PEDro scale to assess the effectiveness of virtual-reality-based exercise therapy in chronic musculoskeletal pain patients. A total of 162 articles were identified from the databases. After applying the inclusion criteria, nine articles were considered suitable for analysis, including six randomized clinical trials. The selected articles were categorized based on study characteristics, virtual-reality-based exercise therapy interventions (including technologies and equipment used), exercise interventions, outcome measures, and effectiveness. The findings indicate that virtual-reality-based exercise therapy shows promising results in reducing pain, improving disability, enhancing range of motion, and increasing treatment satisfaction in patients with chronic musculoskeletal pain. However, it is not possible to conclude that virtual-reality-based exercise therapy is superior to other treatments due to the limited number of available studies, heterogeneity in application protocols, and varying methodological quality. Further research is needed to draw more definitive conclusions.

11 February 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Paraskevi BilikaParaskevi Bilika
Paraskevi Bilika
Jo NijsJo Nijs
Jo Nijs
Evdokia BillisEvdokia Billis
Evdokia Billis
ZDZacharias Dimitriadis
Zacharias Dimitriadis
APACHILLEAS PALIOURAS
ACHILLEAS PALIOURAS
Eleni KapreliEleni Kapreli
Eleni Kapreli
Background/Objectives: The International Association for the Study of Pain (IASP) recently introduced clinical criteria and a grading system to identify nociplastic pain, marking a pivotal step toward improving diagnostic accuracy. This study aimed to evaluate the reliability and validity of the IASP criteria using clinical vignettes, assessing their effectiveness in identifying nociplastic pain in clinical settings. Methods: A reliability and diagnostic accuracy study was conducted using 32 clinical vignettes based on the literature and pre-existing clinical data. The vignettes represented patients with and without the characteristics of nociplastic pain and were reviewed independently by two expert physiotherapists. Inter-rater and intra-rater reliability were evaluated with a 1-month interval between assessments. Criterion validity was analyzed by comparing the IASP criteria against the standardized vignettes as the reference standard. Sensitivity, specificity, and predictive values were calculated to assess diagnostic accuracy. Results: The IASP criteria demonstrated moderate-to-perfect intra-rater agreement (κ = 0.71–1.00, p < 0.05) and weak-to-perfect inter-rater agreement (κ = 0.52–1.00, p < 0.05). Criterion validity was moderate (κ = 0.68), with strong specificity (89.0%) and moderate sensitivity (69.0%). Positive and negative predictive values were high at 81.8% and 81.0%, respectively, supporting the criteria’s accuracy in identifying and excluding nociplastic pain. Conclusions: The IASP criteria for nociplastic pain exhibited satisfactory reliability and criterion validity in this preliminary study, particularly after initial rater familiarization. Future research should evaluate their application in real-world clinical settings, explore concurrent and prognostic validity, and involve a broader range of raters to enhance generalizability.